![](/img/cover-not-exists.png)
Dasatinib, an orally active small molecule inhibitor of both thesrcandablkinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro
Richard S. Finn, Judy Dering, Charles Ginther, Cindy A. Wilson, Padraic Glaspy, Nishan Tchekmedyian, Dennis J. SlamonVolume:
105
Language:
english
Pages:
8
DOI:
10.1007/s10549-006-9463-x
Date:
November, 2007
File:
PDF, 316 KB
english, 2007